Search Results

Your search for Kevin Knopf, MD, MPH, and Charles Bennett, MD, PhD, MPP matches 1 pages

Showing 1 - 1

By Kevin Knopf, MD, MPH, and Charles Bennett, MD, PhD, MPP / July 10, 2017

The Emperor’s New Clothes: Biosimilars and Cost in Oncology

Biosimilars are biologic products similar to the parent (branded) molecule in structure and function—such as erythropoietin and filgrastim (Neupogen).1 To truly bend the cost curve, we want to see a dramatic economic savings achieved as oncology biosimilars for rituximab (Rituxan), trastuzumab...

Nov

Today In Oncology

Inotuzumab Ozogamicin–Based Induction in Older Patients With Philadelphia Chromosome–Negative B-Cell–Precursor ALL

Novel AI Model May Predict Nonsmokers at High Risk for Lung Cancer

Ultraprocessed Food May Heighten Risk of Head and Neck Cancer and Esophageal Adenocarcinoma

Trastuzumab Plus Gemcitabine/Cisplatin in Advanced HER2-Positive Biliary Tract Adenocarcinoma

Incidence of Breast Cancer After False-Positive Mammography